Nigeria, the giant of Africa, has recently experienced a great downturn in its economy, leading to the exodus of several ...

GSK chief executive Emma Walmsley said the new HQ is "an important next step" for the company, which has been under pressure of late following pipeline setbacks and an investor revolt.

Gilead Sciences Canada, Inc. (Gilead Canada) announced today that Paul Petrelli joined the organization as Vice President and General Manager. In his new role, Petrelli will be responsible for leading ...

A St. Louis-based clinical-stage biotechnology company developing cancer-fighting drugs has hired a new medical chief ...

When Hurricane Helene damaged western North Carolina in September, filling medical facilities with people who couldn't be ...

Fewer jabs GSK shares fell owing to a “disappointing” demand for its vaccines during the third quarter of this year. The ...

Pfizer initiated its first major internationalisation at this stage, moving into nine new countries in 1951 ... but buyers including Proctor & Gamble and GSK pulled out of negotiations.

Key to the conversion, as with every new spa opening, Hand & Stone is supporting incoming conversion franchisees by providing a full week of new owner training sessions at Hand & Stone's headquarters ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley ...